INFINITT launches new 3D viz lung solution, analysis software

INFINITT North America, a provider of PACS technology and software development, has introduced it Xelis-Lung solution, a 3D-visualization and analysis tool that uses volume rendering and other post-processing techniques to improve nodule detection and clinicians' workflow in lung cancer screening, diagnosis, pre-surgical planning and treatment evaluation.

The Phillipsburg, N.J.-based company developed its Xelis line of products can be integrated as software modules with its web-based PACS, providing data loading, visualization of large-volume data sets and web-based access from any internet-connected PC.

INFINITT said its Xelis-Lung solution improves utilization of multidetector CT data and offers automated nodule detection for both solid and ground glass opacity-type nodules. It provides 3D nodule volume measurements and other key statistics useful in nodule classification. The system provides three viewing modes: one for manual-detected nodule review followed by manual-detected nodule review, followed by auto-detected review, and one for concurrent manual and automatic detection review.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.